Published in Biomedicine on October 01, 1977
Pathology of articular deposition of calcium salts and their relationship to osteoarthrosis. Ann Rheum Dis (1983) 0.76
Silicon-containing particles in synovial fluid: scanning electron microscopy coupled with analytical techniques allows an easy identification and differentiation from pathologically relevant crystals. Ann Rheum Dis (1985) 0.75
Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol. Ann Rheum Dis (1983) 0.75
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
Mitochondrial genetics. I. Methodology and phenomenology. Symp Soc Exp Biol (1970) 2.92
Mitochondrial nucleic acids in the petite colonie mutants: deletions and repetition of genes. Biochimie (1973) 2.45
Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol (2001) 1.84
Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage (2006) 1.77
The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem (2001) 1.74
Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum (1997) 1.64
Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis (2006) 1.59
Critical sequences within mitochondrial introns: cis-dominant mutations of the "cytochrome-b-like" intron of the oxidase gene. Cell (1982) 1.59
Unsuspected prophage-like elements in Salmonella typhimurium. Mol Microbiol (1997) 1.56
Autosomal dominant spondyloarthropathy. N Engl J Med (1989) 1.54
Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet (1988) 1.50
Fluoride and vertebral fractures. Lancet (1990) 1.48
Mitochondrial antibiotic resistance in yeast: ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin. Biochim Biophys Acta (1973) 1.41
Stereoselective distribution of tiaprofenic acid in synovium and cartilage in osteoarthritic patients. Eur J Clin Pharmacol (1996) 1.40
Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem (1975) 1.39
Fluoroquinolone induced arthralgia and magnetic resonance imaging. J Rheumatol (1996) 1.38
Absence of mesangial IgA in AIDS: a postmortem study. Nephron (1991) 1.38
Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum (2001) 1.35
IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol (1982) 1.34
Analysis of intrachromosomal duplications in yeast Saccharomyces cerevisiae: a possible model for their origin. Mol Biol Evol (2000) 1.32
Mechanism of 3' splice site selection by the catalytic core of the sunY intron of bacteriophage T4: the role of a novel base-pairing interaction in group I introns. Genes Dev (1990) 1.32
Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis (2008) 1.31
Origin and fate of repeats in bacteria. Nucleic Acids Res (2002) 1.30
Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA. J Virol (1996) 1.29
Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest (1983) 1.29
Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum (1990) 1.25
Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol (1992) 1.24
Evaluation of the effect of three surface treatments on the biocompatibility of 316L stainless steel using human differentiated cells. Biomaterials (1996) 1.23
Magnetic resonance imaging in osteoarthritis: which method best reflects synovial membrane inflammation? Correlations with clinical, macroscopic and microscopic features. Osteoarthritis Cartilage (2009) 1.21
Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett (2002) 1.21
Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem (1995) 1.20
Mitochondrial genetics. XI. Mutations at the mitochondrial locus omega affecting the recombination of mitochondrial genes in Saccharomyces cerevisiae. Mol Gen Genet (1976) 1.20
Study of intrachromosomal duplications among the eukaryote genomes. Mol Biol Evol (2001) 1.20
Scanning electron microscopic study of microcrystals implicated in human rheumatic diseases. Scan Electron Microsc (1980) 1.20
Mitochondrial genetics. VII. Allelism and mapping studies of ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin in S. cerevisiae. Genetics (1974) 1.19
[Hepatitis caused by non-steroidal anti-inflammatory agents. A cooperative evaluation of regional centers of drug surveillance for 1985]. Therapie (1988) 1.19
Molecular basis of the 'box effect', A maturase deficiency leading to the absence of splicing of two introns located in two split genes of yeast mitochondrial DNA. Eur J Biochem (1984) 1.15
Accuracy of respiratory rate monitoring using a non-invasive acoustic method after general anaesthesia. Br J Anaesth (2012) 1.15
[A controlled clinical trial for testing the efficacy of the homeopathic drug eupatorium perfoliatum D2 inthe treatment of common cold (author's transl)]. Arzneimittelforschung (1981) 1.14
Immunohistologic localization of "facteur thymique serique" (FTS) in human thymic epithelium. J Immunol (1981) 1.14
Hereditary diffuse articular chondrocalcinosis. Dominant manifestation without close linkage with the HLA system in a large pedigree. Scand J Rheumatol (1977) 1.09
Insufficiency fractures of the ilium. Rev Rhum Engl Ed (1997) 1.09
Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum (1999) 1.07
Graves' disease: in situ localization of lymphoid T cell subpopulations. Clin Exp Immunol (1983) 1.07
Dialysis-associated arthropathy: a multicentre survey of 171 patients receiving haemodialysis for over 10 years. The Co-operative Group on Dialysis-associated Arthropathy. Br J Rheumatol (1992) 1.06
[Are coffee and alcohol consumption risk factors in pregnancy? (author's transl)]. Geburtshilfe Frauenheilkd (1974) 1.06
Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repair. Proc Natl Acad Sci U S A (2004) 1.05
Features of tendon disorders with fluoroquinolones. Therapie (1994) 1.05
Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob Agents Chemother (2000) 1.03
Interaction between cyclosporin and erythromycin in a kidney transplant patient. Eur J Clin Pharmacol (1986) 1.02
Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest (1998) 1.01
Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies. Br J Clin Pharmacol (1991) 1.00
Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med (1998) 1.00
Impact of a physician-staffed helicopter on a regional trauma system: a prospective, controlled, observational study. Acta Anaesthesiol Scand (2013) 1.00
Monocrystalline calcium hydrogen phosphate dihydrate in destructive arthropathies of chondrocalcinosis. Lancet (1977) 0.99
Expression of the mitochondrial split gene coding for cytochrome oxidase subunit I in S. cerevisiae: RNA splicing pathway. Curr Genet (1986) 0.99
Psychosocial stress in tree shrews: clomipramine counteracts behavioral and endocrine changes. Pharmacol Biochem Behav (1996) 0.99
High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med (2000) 0.98
Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis. Osteoarthritis Cartilage (2004) 0.98
Anhydrous lead(II) heptanoate. Acta Crystallogr C (2001) 0.98
Changes in lactoferrin and lysozyme levels in human milk during the first twelve weeks of lactation. Adv Exp Med Biol (2001) 0.97
Aseptic loosening of cemented total arthroplasties of the hip in relation to positioning of the prosthesis. New utilization of the Tschuprow-Cramer statistical test. Acta Orthop Scand (1981) 0.97
Sodium alginate sponges with or without sodium hyaluronate: in vitro engineering of cartilage. J Biomed Mater Res (2001) 0.97
Hepatitis induced by non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1989) 0.97
[Toxicity and pharmacokinetics of zirconium oxychloride in mice and rats]. J Pharmacol (1984) 0.96
The effect of variation in the apolipoprotein B gene on plasmid lipid and apolipoprotein B levels. I. A likelihood-based approach to cladistic analysis. Ann Hum Genet (1994) 0.96
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease. Am J Hum Genet (1999) 0.96
Potassium chloride tablets and small bowel stenoses and perforations: two studies in the French Pharmacovigilance system. Am J Gastroenterol (1994) 0.96
Septicemia with two distinct strains of Staphylococcus aureus and dwarf variants of both. Isr J Med Sci (1985) 0.95
Intragenic suppressors reveal long distance interactions between inactivating and reactivating amino acid replacements generating three-dimensional constraints in the structure of mitochondrial cytochrome b. J Biol Chem (1990) 0.95
An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet (1989) 0.95
The Beck Depression Inventory and Research Diagnostic Criteria: congruence in an older population. J Consult Clin Psychol (1983) 0.95
Cytocompatibility of Ti-6Al-4V and Ti-5Al-2.5Fe alloys according to three surface treatments, using human fibroblasts and osteoblasts. Biomaterials (1996) 0.95
A comparative study of duplications in bacteria and eukaryotes: the importance of telomeres. Mol Biol Evol (1997) 0.95
Plasma and cerebrospinal fluid concentrations of indomethacin in humans. Relationship to analgesic activity. Eur J Clin Pharmacol (1990) 0.94
Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol (1997) 0.94
Improvement of cellular immunity and IgA production in immunodeficient children after treatment with synthetic serum thymic factor (FTS). Lancet (1982) 0.93
[Spondylarthropathies or ossifying polyenthesitis. Scintigraphic and scanographic evidence]. Rev Rhum Mal Osteoartic (1987) 0.93
Total and free ketoprofen in serum and synovial fluid after intramuscular injection. Clin Pharmacol Ther (1987) 0.93
Magnetic resonance imaging may be an asset to diagnose and classify fluoroquinolone-associated Achilles tendinitis. Fundam Clin Pharmacol (1995) 0.93
Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporos Int (1998) 0.92